Published 1 day ago • loading... • Updated 1 day ago

More effective medical imaging, treatment for prostate cancer coming to Kelowna

BC Cancer is introducing a new prostate-specific imaging technology to Kelowna in May 2025 to improve medical imaging and treatment for prostate cancer.
This advancement follows clinical trials starting in 2017 and a 2021 fundraising campaign that raised $6.4 million from over 1,000 donors for equipment, renovations, and start-up costs.
Since 2024, patients in the Lower Mainland have had access to an advanced imaging method that employs radioactive tracers to identify a protein highly expressed on prostate cancer cells, enabling more precise detection compared to traditional scans.
The new treatment Pluvicto, targeting metastatic castration-resistant prostate cancer with high-energy radiation bound directly to cancer cells, will become available in the Interior Health region later this year as part of a broader provincial rollout.
Health Minister Josie Osborne emphasized that expanding advanced diagnostic and treatment services across more regions of British Columbia will improve access to lifesaving care, supporting individuals in managing and overcoming prostate cancer. In 2025, the province anticipates approximately 4,165 new prostate cancer cases.

Insights by Ground AI

Does this summary seem wrong?